BeOne Medicines Ltd. 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001628280-26-011946
- Form type
- 10-K
- CIK
- 0001651308
- Primary document
- https://www.sec.gov/Archives/edgar/data/1651308/000162828026011946/bgne-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BeOne Medicines Ltd..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $5.3B | - | - |
| Gross Profit | $4.7B | - | - |
| Operating Income | $447.1M | - | - |
| Net Income | $286.9M | - | - |
| Eps Basic | 0.2 | - | - |
| Eps Diluted | 0.19 | - | - |
| Cash And Equivalents | $4.5B | - | - |
| Total Assets | $8.2B | - | - |
| Total Liabilities | $3.8B | - | - |
| Shareholders Equity | $4.4B | - | - |
| Operating Cash Flow | $1.1B | - | - |
| Capital Expenditures | $185.8M | - | - |